2024 Speakers

Adrien Savy, Next Generation Gene Therapy Vectors

Adrien Savy

AAV Principal Scientist

Coave Therapeutics

Alessio Cantore

Group Leader

San Raffaele-Telethon Institute for Gene Therapy

Alex Goraltchouk

Chief Operating Officer

Remedium Bio

Allison Dane

Senior Director, R&D

AskBio

Amanda Placone

Senior Director, External Innovation & Early Commercial Strategy

Eli Lilly & Co.

Andrew Murray

Chief Executive Officer and Founder

Sania Therapeutics

Brett hoffman

Senior Scientist II, Novel Capsid Discovery

Voyager Therapeutics

Caroline Xu

Co-Founder & Chief Executive Officer

ViGeneron GmbH

Christopher Lim - GenixCure

Christopher Lim

Chief Business Development & Finance Officer

GenixCure

Costanza Gorini - Next Generation Gene Therapy Vectors

Costanza Gorini

Senior Research Analyst

Beacon

Daniel Cohen

Senior Director, Head of Vector Optimization

Spark Therapeutics

Darin Falk

Vice President, Discovery and Early Preclinical Development

Neurogene Inc.

David Goertsen

Senior Scientist

Capsida Biotherapeutics

Devarshi Kapadia

Associate Director, Commercial Development Licensing

Lonza

Don Haut

Chief Business Officer

EG427

Eric Kelsic

Founder and Chief Executive Officer

Dyno Therapeutics

Geeta Vemuri

Founder & Managing Partner

Agent Capital

Jing Liao

Head of Vector Technology

Alexion Pharmaceuticals

Joseph Nabhan

Chief Scientific Officer

Vesigen Therapeutics

Jun Xie

Associate Professor & Director of Vector Development, Viral Vector Core

UMass Medical School

Leszek Lisowski

Unit Head, Translational Vectorology Research Unit

Children's Medical Research Institute

Lucia Faccio

Partner

Sofinnova Partners

Marc Abrams

Chief Scientific Officer

Carbon Biosciences

Michelle Fraser Revvity - Next Generation Gene Therapy Vectors Summit

Michelle Fraser

Head of Cell and Gene Therapy

Revvity

Morten Sogaard

President, Astellas Gene Therapy & Technical Operations

Astellas Gene Therapies Inc

Paul Heppenstall

Founder

Borea Therapeutics

Robert Lin

Chief Executive Officer

Avista Therapeutics

Roxanne Croze

Senior Director, Vector Innovation

4D Molecular Therapeutics

Simon Pacouret

Senior Research Scientist

The Broad Institute of MIT & Harvard

Teddy Jégu

Director of Research

EG427

Tetsuya Yamagata - Next Generation Gene Therapy Vectors

Tetsuya Yamagata

CSO

Modalis Therapeutics